Jubilant to acquire radiopharmacy business of US-based Triad Isotopes

Triad operates the second largest radiopharmacy network in the US with more than 50 pharmacies

Premium

Triad Isotopes

Rakesh Rao Mumbai

Last Updated : May 05 2017 | 12:06 PM IST

The Noida-based Jubilant Pharma Limited (JPL), a wholly owned subsidiary of Jubilant Life Sciences Limited, has agreed to acquire the radiopharmacy business of the US-based Triad Isotopes for an undisclosed amount. For this, an asset purchase agreement was signed by JPL with Triad Isotopes and its parent, Isotope Holdings Inc.

The acquisition will be funded through JPL’s internal accruals and is likely to be earnings accretive in the first full year of operations.

Triad recorded revenues in excess of $ 225 million in 2016 with positive EBITDA and operates the second largest radiopharmacy network in the US with more than 50 pharmacies, distributing

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in